{
  "docId": "019dd923-5f69-752d-a9b6-2758ff8024b8",
  "docSlug": "IOYPUci1JeH6qtF9hngI",
  "documentTitle": "See the 21-slide pitch deck a biotech startup used to convince investors like Pfizer to bet on fixing damaged organs",
  "authorId": "Pitchdecks",
  "authorName": "Agomab Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 12,
  "pageCount": 21,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "action_title",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b6-2758ff8024b8/12",
  "deckHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.94,
        "x": 0.03,
        "y": 0.235
      },
      "kind": "list",
      "text": "Advantageous drug properties: Inhaled, potent and lung-restricted small molecule inhibitor of ALK-5; Tissue restriction through rapid hydrolyzation in the bloodstream; Clean profile for hERG, cardiac ion channels and kinase panels",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36c37ca1-3fc6-4a8d-b205-759b3650b64e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.94,
        "x": 0.03,
        "y": 0.641
      },
      "kind": "list",
      "text": "Development status: GLP toxicology studies ongoing; CMC upscaling & optimization ongoing; Ph1 in healthy volunteers planned for H1'2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6148af26-b06a-4e0d-9f6d-1280dad5b7b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.94,
        "x": 0.03,
        "y": 0.438
      },
      "kind": "list",
      "text": "Well-characterized profile: Clear efficacy in therapeutic BLM mouse model and ex vivo experiments; Confirmed lung-restricted PK profile in mouse & rat; Wide safety margins in safety battery studies & non-GLP tox studies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85a8f510-ca6e-4a85-98ef-012abca41fb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.76,
        "x": 0.12,
        "y": 0.07
      },
      "kind": "title",
      "text": "AGMB-447 is a novel candidate for the treatment of IPF",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "edc8fe43-a0f7-45ad-b77e-749096631ed5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}